CSIMarket Company Name, Ticker, Competitors, else..
 
Stemtech Corporation  (STEK)
Other Ticker:  
 
 

Stemtech Growth Comparisons

Select each growth Category to receive further Information



STEK Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 17.52 % 7.11 % 5.71 % 3.23 %
Q / Q Revenue Growth (Q2 MRQ) -4.11 % -4.45 % -3.24 % -1.67 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 46.12 % 52.72 % 15.16 % %
Seq. Revenue Growth (for 12 months ending Q2 TTM) 3.81 % 6.27 % 2.64 % 0.73 %
Revenue 5 Year Average Growth - 12.73 % 9.51 % 7.61 %


STEK's Growth Comparisons in II. Quarter 2024




Facing 17.52% year on year sales decrease in the second quarter 2024, to $ 1 millions, Stemtech reported smaller declines than the Pharmacy Services & Retail Drugstore industry with 7.11%, and less than 5.71% growth in the Retail sector. Above average sales gains in the Pharmacy Services & Retail Drugstore industry, as well as, in the Retail, helped to elevate overall market growth to 3.23%.

Top-line fell by -4.11% from the first quarter. Average annual sales growth for Stemtech is %, while S & P 500's average yearly sales increase is 7.61%, including only Businesses with the second quarter 2024 financial results.

STEK Growth Rates by Company's Segments

Segment Name
Y / Y
Seq.
Total
17.52 %
0 %


Growth Rates of STEK's Income in the second quarter 2024


STEK Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) - - -2.11 % 8.41 %
Seq. Operating Income Change (Q2 MRQ) - - -5.23 % 10.01 %
Y / Y Operating Income Growth (Q2 TTM) - 15.63 % 13.67 % -2.87 %
Seq. Operating Income Growth (Q2 TTM) - -65.98 % -2.01 % 3.34 %
Operating Income 5 Year Avg. Change - 3.05 % 4.95 % 9.13 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - - -2.21 % -0.3 %
Seq. Income from Cont. Ops. Change (Q2 MRQ) - - -9.89 % 9.55 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) - -84.75 % 24.55 % -3.44 %
Seq. Income from Cont. Ops. Change (Q2 TTM) - -94.73 % -2.37 % -0.12 %
Income from Cont. Ops. 5 Year Avg. Change - 14.46 % 12.1 % 7.3 %

STEK Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) - - -2.29 % -0.36 %
Q / Q Net Income Growth (Q2 MRQ) - - -9.94 % 12 %
Y / Y Net Income Change (Q2 TTM) - -84.74 % 24.31 % -2.23 %
Seq. Net Income Change (Q2 TTM) - -94.73 % -2.39 % -0.14 %
Net Income 5 Year Avg. Growth - 9.3 % 11.65 % 7.44 %

STEK's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) - - -2.21 % -0.3 %
Seq. EPS from Cont. Ops. Change (Q2 MRQ) - - -9.89 % 9.55 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) - 32.91 % - -
Seq. EPS from Cont. Ops. Change (Q2 TTM) - -15.58 % 11.35 % 45.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - 20.68 % 12.1 % 7.3 %



STEK EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) - - -2.29 % -0.36 %
Q / Q EPS Net Growth (Q2 MRQ) - - -9.94 % 12 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - 20.59 % 47.5 % 85294.14 %
Seq. EPS Net Change (for 12 months ending Q2 TTM) - -16.88 % 8.95 % 46.15 %
EPS Net 5 Year Avg. Change - 9.3 % 11.65 % 7.44 %



Stemtech reported bottom-line of $ -0.01 in the second quarter, compare to $ 0.00 in the same quarter a year ago. Pharmacy Services & Retail Drugstore industry grew by 7.11%, while Retail sector decreased by -2.29%, and overall market declined by -0.36%.

the bottom-line fell by -4.11% from the first quarter. Average annual income per share growth for Stemtech is %, while S & P 500's average yearly income per share increase is 7.44%, including only Businesses with the second quarter 2024 earnings.

STEK Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) - -35.42 % 30.12 % -31.66 %
Seq. Free Cash Flow Change (Q2 MRQ) - - -41.03 % -73.49 %
Y / Y Free Cash Flow Change (Q2 TTM) - -27.82 % -4.94 % -3.72 %
Seq. Free Cash Flow Change (Q2 TTM) - -16.67 % 3.59 % -3.85 %
Free Cash Flow 5 Year Avg. Change - 0.06 % 7.27 % 11.94 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - 104.59 % - -
Seq. Net Cash Flow Change (Q2 MRQ) - - - -
Y / Y Net Cash Flow Change (Q2 TTM) - - 73.08 % -
Seq. Net Cash Flow Change (Q2 TTM) - - 69.02 % -
Net Cash Flow 5 Year Avg. Change - - - -33.53 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) - -18.29 % 14.64 % 4.3 %
Seq. Capital Expenditures Change (Q2 MRQ) - -14.84 % -8.36 % -13.23 %
Y / Y Capital Expenditures Change (Q2 TTM) - 10.55 % -46.48 % 18.86 %
Seq. Capital Expenditures Change (Q2 TTM) - -3.59 % -1.32 % -0.58 %
Capital Expenditures 5 Year Avg. Change - 8.42 % 11.2 % 8.99 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com